Relief Therapeutics Holding SA announced that it has entered into a share subscription agreement to issue shares for the gross proceeds of CHF 50 million on February 28, 2024. The transaction will include participation from returning investors, GEM Global Yield Fund, L.P., a fund managed by, Global Emerging Markets and new investor, GEM Yield Bahamas Limited.